|
|
Ypsomed Holding AG - Comparative Business Analysis Snapshot
Business Description
Ypsomed Holding AG. The Group's principal activities are to develop, manufacture and sells custom made injection pens for the treatment of diabetes, growth disorders or infertility also for further therapeutic areas. The products of the Group include disposable pens, reusable pens with variable dose setting and electronic display, auto injectors and a variety of pen needles. The Group's operations are located in Switzerland, Rest of Europe, North America and Other Countries.
Competitor Analysis
This analysis compares Ypsomed Holding AG with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
